Silvana Gaetani Selected Research

Silvana Gaetani Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 01/2014
8	Feeding and Eating Disorders (Eating Disorder) 01/2023 - 09/2003
7	Obesity 01/2023 - 01/2015
5	Body Weight (Weight, Body) 01/2020 - 09/2003
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2014
3	Insulin Resistance 09/2022 - 10/2018
2	Neuroinflammatory Diseases 09/2022 - 01/2017
2	Mood Disorders (Mood Disorder) 09/2021 - 01/2009
2	Bulimia (Binge Eating) 12/2019 - 08/2014
2	Parkinson Disease (Parkinson's Disease) 01/2016 - 03/2014
1	Hyperglycemia 09/2022
1	Food Addiction 09/2021
1	Pain (Aches) 01/2020
1	Disease Progression 10/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Autistic Disorder (Autism) 01/2015
1	Polydipsia 10/2014
1	Neuroblastoma 03/2014
1	Seizures (Absence Seizure) 08/2010
1	Cognitive Dysfunction 09/2007
1	Hyperlipidemias (Hyperlipidemia) 06/2005

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 08/2021 - 09/2003
4	oleoylethanolamideIBA 01/2023 - 06/2005
4	EndocannabinoidsIBA 01/2023 - 01/2014
3	CannabinoidsIBA 01/2020 - 08/2010
3	PPAR alphaIBA 08/2006 - 09/2003
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 06/2005
2	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 10/2018
2	Neurotransmitter Agents (Neurotransmitter)IBA 09/2022 - 08/2014
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2021 - 01/2017
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2020 - 01/2015
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2005 - 09/2003
1	Protein Disulfide-IsomerasesIBA 02/2023
1	N-acylethanolaminesIBA 01/2023
1	ferulic acid (sodium ferulate)IBA 09/2022
1	SolutionsIBA 09/2021
1	Triglycerides (Triacylglycerol)IBA 08/2021
1	Oleic Acid (Oleate)IBA 08/2021
1	Transaminases (Aminotransferases)IBA 08/2021
1	AntioxidantsIBA 08/2021
1	SaltsIBA 01/2020
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	PF 3845IBA 01/2020
1	SugarsIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2019
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2019
1	Insulin (Novolin)FDA Link 04/2019
1	Peptides (Polypeptides)IBA 04/2019
1	biliverdin reductaseIBA 04/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	MTOR InhibitorsIBA 01/2019
1	Everolimus FDA Link 01/2019
1	HexosaminesIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	NeuropeptidesIBA 06/2018
1	palmidrolIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	CB2 Cannabinoid ReceptorIBA 01/2017
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 12/2016
1	tau Proteins (tau Protein)IBA 03/2016
1	CholesterolIBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2015
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2015
1	QuinpiroleIBA 10/2014
1	Dopamine (Intropin)FDA LinkGeneric 10/2014
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 08/2014
1	CRF receptor type 1IBA 08/2014
1	pyrimidineIBA 08/2014
1	Corticotropin-Releasing HormoneIBA 08/2014
1	R 121919IBA 08/2014
1	5-S-cysteinyldopamineIBA 03/2014
1	Oxidopamine (6 Hydroxydopamine)IBA 03/2014
1	SynucleinsIBA 03/2014
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2014
1	PlasticsIBA 08/2010
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2009
1	Antidepressive Agents (Antidepressants)IBA 01/2009
1	Dronabinol (THC)FDA LinkGeneric 09/2007
1	Leptin ReceptorsIBA 06/2005
1	OleylethanolamideIBA 09/2003

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2009
1	Fat-Restricted Diet (Diet, Fat Restricted) 08/2021
1	Drug Therapy (Chemotherapy) 10/2020
1	Injections 08/2014